Pieter de Boer is a health economist specialised in interventions against infectious diseases. As health budgets are limited, decisions have to be made as to whether a health intervention should be reimbursed or not. Cost-effectiveness analyses help decision makers to weigh costs and benefits of interventions, and to relate these to the corresponding health gains. This way interventions can be compared, and the health budget can optimized to maximize health gains. Pieter's work ranges from modelling the impact of vaccination on the transmission of infectious diseases, to advising policymakers on decisions around immunization programs, taking into account ethical considerations. In his current project, Pieter evaluates the cost-effectiveness of a screening program for chronic Q-fever infections.

Pieter de Boer


Pieter de Boer studied Biology and Medical Laboratory Research at the Van Hall Institute in Leeuwarden, and Pharmacy at the University of Groningen. During his thesis at the University of Groningen he worked at the unit of Pharmacotherapy, -Epidemiology and -Economis. He specialized in Pharmacoeconomics by performing cost-effectiveness analyses of vaccination against influenza and shingles.